about
Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cellsRestoration of mitochondria function as a target for cancer therapyNeem components as potential agents for cancer prevention and treatmentNanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W speciesDefective molecular timer in the absence of nucleotides leads to inefficient caspase activationBax-dependent regulation of Bak by voltage-dependent anion channel 2.Mitochondrial and postmitochondrial survival signaling in cancer.Androgen receptor mutations and polymorphisms in African American prostate cancer.Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation.Transformations of the macromolecular landscape at mitochondria during DNA-damage-induced apoptotic cell death.Curcumin induces Apaf-1-dependent, p21-mediated caspase activation and apoptosis.Functional evidence that the self-renewal gene NANOG regulates human tumor developmentLipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer.Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agentsGenetic insights into OXPHOS defect and its role in cancerA potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapyBim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer.Mechanism of neem limonoids-induced cell death in cancer: Role of oxidative phosphorylation.Neem oil limonoids induces p53-independent apoptosis and autophagy.Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American WomenMitochondrial dysfunction-mediated apoptosis resistance associates with defective heat shock protein response in African-American men with prostate cancer.Mitochondrial DNA mutations and breast tumorigenesis.Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer.Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome.Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS.Mitochondrially localized active caspase-9 and caspase-3 result mostly from translocation from the cytosol and partly from caspase-mediated activation in the organelle. Lack of evidence for Apaf-1-mediated procaspase-9 activation in the mitochondriaDetection of apoptosis in cell-free systems.Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer.Modulation of glyoxalase, glutathione S-transferase and antioxidant enzymes in the liver, spleen and erythrocytes of mice by dietary administration of fenugreek seeds.Radiation induced oxidative stress: II studies in liver as a distant organ of tumor bearing mice.Early mitochondrial activation and cytochrome c up-regulation during apoptosis.Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells.International conference on Cell Death in Cancer and Toxicology 2018 (CDCT-2018).Investigation of prostate cancer cells using NADH and Tryptophan as biomarker: multiphoton FLIM-FRET microscopyModulation of radioresponse of glyoxalase system by curcuminInfluence of methylglyoxal on antioxidant enzymes and oxidative damageCytochrome c Deficiency Confers Apoptosome and Mitochondrial Dysfunction in African-American Men with Prostate Cancer
P50
Q24292284-8EA06561-8AA1-4B50-9072-7032A44CE9FCQ26864167-FAB76E92-DCD6-4E82-8382-58CCD502B285Q26995699-6FC1276F-789A-492B-9311-9A424F3EDE64Q28540510-526FB354-172E-4CDF-B641-DB8A0A6F5C84Q30998000-5D7F477E-B04B-4E40-8B6F-B56AC83876A8Q33212700-7BD97358-FD61-4CF6-8095-41F88D97362BQ33645577-E3740844-3CA6-4F92-82A1-77551F29671EQ33775730-F8210EB2-020D-43FA-9765-C69FA68E971AQ35005096-563D8057-3C4F-4880-8802-7299D082D1C0Q35309349-2F40E344-5373-4943-8ABB-DE7E2B72387DQ35317287-E5888AA0-814A-48F4-A450-082F27FB042BQ35737599-009E40F0-C876-401F-B6EC-ACD264A13830Q35891426-ED858B34-39C4-4BE5-BE89-E1C46498C25EQ36323141-422F84EF-C494-4832-AE3B-592A77EFAA22Q36349917-9C31380F-F40C-4AC1-83B1-C0813C9A8333Q36377723-A5AF311A-7E7C-46DC-8497-E573DDA95F07Q36495236-309885A2-C96B-48A9-A21E-930CC8AB5916Q36508651-A5CAA1FE-4CC3-44C2-B5AC-2CDA112860E1Q36524971-137609FC-ABFB-424F-940C-C52E9313C7B6Q36647000-ACE6286F-C11A-4050-A6AC-EF1C9A3720BBQ36812955-38F225DB-A08E-4A8E-831B-1E694852CA54Q36898439-DD9A3E10-7691-4FCB-AC3B-443D68063847Q37477802-34899361-56F1-4BDB-8E8E-FE74354ED6C0Q39042225-F3CDA158-E662-4AE0-A51E-EF6972DE4976Q40260722-E161BB00-B22E-4A89-BD59-0C90B5C30347Q40464860-9FB932BB-0B56-4F35-A19E-BFCE51398051Q40667287-A882929A-DC48-4202-BF30-9449514B9F0EQ41939242-DD448DD5-330A-4501-A4B1-9CC43CD4D2ADQ42382167-167C37CB-409E-4164-B904-5059E031563BQ43720970-4C911568-4926-48C9-B435-49CC5548752EQ43788146-A01069FC-192A-4CA1-A618-3FE4C627532CQ44198666-640AB4C6-547B-4E4E-996B-C94525DEBB41Q46268031-633B442D-FA77-440E-86CF-FE347E96C1D6Q55517084-84D24A3F-ABC2-49F2-B32E-696C6EB8539BQ57445027-8BD293D1-A81A-4F5C-AEFA-983B79DD980DQ61771983-F7D89581-A7CE-4852-BE73-0AD596AA9BCCQ61771985-B5089669-AF6F-4F72-B7F1-8A5C15B7E2FBQ91595524-8CAAB7D5-F04A-4E0B-8156-40F573F939C7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dhyan Chandra
@ast
Dhyan Chandra
@en
Dhyan Chandra
@es
Dhyan Chandra
@nl
Dhyan Chandra
@sl
type
label
Dhyan Chandra
@ast
Dhyan Chandra
@en
Dhyan Chandra
@es
Dhyan Chandra
@nl
Dhyan Chandra
@sl
prefLabel
Dhyan Chandra
@ast
Dhyan Chandra
@en
Dhyan Chandra
@es
Dhyan Chandra
@nl
Dhyan Chandra
@sl
P106
P1153
7103046565
P31
P496
0000-0001-7272-9384
P569
2000-01-01T00:00:00Z